These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25593102)

  • 1. Spinocerebellar ataxia 36 (SCA36): «Costa da Morte ataxia».
    Arias M; García-Murias M; Sobrido MJ
    Neurologia; 2017; 32(6):386-393. PubMed ID: 25593102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Costa da Morte' ataxia is spinocerebellar ataxia 36: clinical and genetic characterization.
    García-Murias M; Quintáns B; Arias M; Seixas AI; Cacheiro P; Tarrío R; Pardo J; Millán MJ; Arias-Rivas S; Blanco-Arias P; Dapena D; Moreira R; Rodríguez-Trelles F; Sequeiros J; Carracedo A; Silveira I; Sobrido MJ
    Brain; 2012 May; 135(Pt 5):1423-35. PubMed ID: 22492559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebellar Cognitive Affective Syndrome in Costa da Morte Ataxia (SCA36).
    Martínez-Regueiro R; Arias M; Cruz R; Quintáns B; Labella-Caballero T; Pardo M; Pardo J; García-Murias M; Carracedo A; Sobrido MJ; Fernández-Prieto M
    Cerebellum; 2020 Aug; 19(4):501-509. PubMed ID: 32270466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of SCA36: a novel spinocerebellar ataxia with motor neuron involvement (Asidan).
    Ikeda Y; Ohta Y; Kobayashi H; Okamoto M; Takamatsu K; Ota T; Manabe Y; Okamoto K; Koizumi A; Abe K
    Neurology; 2012 Jul; 79(4):333-41. PubMed ID: 22744658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spinocerebellar ataxia type 36 (nicknamed Asidan)].
    Abe K; Ikeda Y
    Brain Nerve; 2012 Aug; 64(8):937-41. PubMed ID: 22868885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain.
    Baviera-Muñoz R; Carretero-Vilarroig L; Muelas N; Sivera R; Sopena-Novales P; Martínez-Sanchis B; Sastre-Bataller I; Campins-Romeu M; Martínez-Torres I; García-Verdugo JM; Millán JM; Jaijo T; Aller E; Bataller L
    Mov Disord Clin Pract; 2023 Jun; 10(6):992-997. PubMed ID: 37332636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinocerebellar ataxia type 36 exists in diverse populations and can be caused by a short hexanucleotide GGCCTG repeat expansion.
    Obayashi M; Stevanin G; Synofzik M; Monin ML; Duyckaerts C; Sato N; Streichenberger N; Vighetto A; Desestret V; Tesson C; Wichmann HE; Illig T; Huttenlocher J; Kita Y; Izumi Y; Mizusawa H; Schöls L; Klopstock T; Brice A; Ishikawa K; Dürr A
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):986-95. PubMed ID: 25476002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement.
    Kobayashi H; Abe K; Matsuura T; Ikeda Y; Hitomi T; Akechi Y; Habu T; Liu W; Okuda H; Koizumi A
    Am J Hum Genet; 2011 Jul; 89(1):121-30. PubMed ID: 21683323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and clinical analysis of spinocerebellar ataxia type 36 in Mainland China.
    Zeng S; Zeng J; He M; Zeng X; Zhou Y; Liu Z; Xia K; Pan Q; Jiang H; Shen L; Yan X; Tang B; Wang J
    Clin Genet; 2016 Aug; 90(2):141-8. PubMed ID: 26661328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat expansions in
    Lam T; Rocca C; Ibanez K; Dalmia A; Tallman S; Hadjivassiliou M; Hensiek A; Nemeth A; Facchini S; ; Wood N; Cortese A; Houlden H; Tucci A
    Brain Commun; 2023; 5(5):fcad244. PubMed ID: 37810464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for spinocerebellar ataxia type 36 (SCA36) in the Greek population.
    Katsimpouris D; Kartanou C; Breza M; Panas M; Koutsis G; Karadima G
    J Neurol Sci; 2019 Jul; 402():131-132. PubMed ID: 31132534
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical characteristics of spinocerebellar ataxia 36: a study of 2121 Japanese ataxia patients.
    Sugihara K; Maruyama H; Morino H; Miyamoto R; Ueno H; Matsumoto M; Kaji R; Kitaguchi H; Yukitake M; Higashi Y; Nishinaka K; Oda M; Izumi Y; Kawakami H
    Mov Disord; 2012 Aug; 27(9):1158-63. PubMed ID: 22753339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in clinical and genetic research of spinocerebellar ataxia type 36].
    Zeng S; Tang B; Wang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):886-9. PubMed ID: 26663071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinocerebellar ataxia type 36 in the Han Chinese.
    Lee YC; Tsai PC; Guo YC; Hsiao CT; Liu GT; Liao YC; Soong BW
    Neurol Genet; 2016 Jun; 2(3):e68. PubMed ID: 27123487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and affective impairments of a novel SCA/MND crossroad mutation Asidan.
    Abe K; Ikeda Y; Kurata T; Ohta Y; Manabe Y; Okamoto M; Takamatsu K; Ohta T; Takao Y; Shiro Y; Shoji M; Kamiya T; Kobayashi H; Koizumi A
    Eur J Neurol; 2012 Aug; 19(8):1070-8. PubMed ID: 22353375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole Exome Sequencing Indicating GGCCTG Hexanucleotide Repeat in Patients with Spinocerebellar Ataxia Type 36.
    Chen R; Zhou C; Peng Y; Huang P; Yu Y; Zhu M; Zhou M; Hong D; Tan D
    Neurodegener Dis; 2024 Jun; ():1-9. PubMed ID: 38934198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the Largest SCA36 Pedigree in Asia: with Multimodel Neuroimaging Evaluation for the First Time.
    Xie Y; Chen Z; Long Z; Chen RT; Jiang YZ; Liu MJ; Peng LL; Peng HR; Wan N; Zou G; Wang CR; Shi YT; Zhou GF; Liao WH; Qiu R; Hu ZM; Xia K; Tang BS; Jiang H
    Cerebellum; 2022 Jun; 21(3):358-367. PubMed ID: 34264505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36.
    Aguiar P; Pardo J; Arias M; Quintáns B; Fernández-Prieto M; Martínez-Regueiro R; Pumar JM; Silva-Rodríguez J; Ruibal Á; Sobrido MJ; Cortés J
    Mov Disord; 2017 Feb; 32(2):264-273. PubMed ID: 27862279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acoustic impairment is a distinguishable clinical feature of Asidan/SCA36.
    Ikeda Y; Ohta Y; Kurata T; Shiro Y; Takao Y; Abe K
    J Neurol Sci; 2013 Jan; 324(1-2):109-12. PubMed ID: 23140984
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.